- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03111004
BeyondSilos - More Personalised and Coordinated Care and Improved Outcomes for Elderly Patients (BeyondSilos)
BeyondSilos - Integrated Care Leading to a More Personalised and Coordinated Care, Improving Outcomes for Elderly Patients, Delivering More Effective Care and Support, and Provide More Cost Efficient Health and Social Services
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overall aim of the evaluation carried out in BeyondSilos is to identify the differences introduced by implementing ICT supported integrated care in different domains according to the MAST evaluation framework, including safety, clinical and social outcomes, resource use and cost of care, user/carer experience and organisational changes.
The focus of the evaluation will be the impact of so called "horizontal" integration, which is the integration between social care and health care, and the changing organisational models for elderly patients.
The hypothesis in this study is that integrated care (IC) will lead to a more personalised and coordinated care, improve outcomes for elderly patients, deliver more effective care and support, and provide more cost efficient health and social services.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Potential participants are selected by screening electronic healthcare and social care records or/and the hospital / national databases and/or during long term condition annual reviews in the community setting. If necessary, candidates are informed about the nature and the objectives of the evaluation. If a candidate passes the inclusion/exclusion criteria and signs the informed consent form, if necessary, they participate in the evaluation.
Inclusion Criteria:
- Age ≥65 years.
- Presence of health needs specified as: Presence of heart failure, stroke, COPD or diabetes (diagnosed at hospital or at specialist visit) plus at least one additional chronic disease / condition included in the Charlson Comorbidity Index (CCI).
- Presence of social needs based on Barthel Index of Activities of Daily Living and Instrumental Activities of Daily Living (IADL).
- Reasonable expectation of permanence in the BeyondSilos project for the whole data collection period (18 months).
- Informed consent, signed if necessary (by the subject or his/her delegate).
- Capability to handle ICT equipment / devices alone, or with the help from a delegate.
- Presence of good/reliable communication connection at home (internet, telephone or what is needed for the ICT connection).
Exclusion Criteria:
Subjects who have been registered with an active cancer diagnosis and undergoing treatment, has undergone an organ transplant, or is undergoing dialysis prior to enrolment.
- Subjects in a terminal state
- People with an AIDS diagnose.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Group
The Study Group receives 'new care' (integrated health and social care)
|
All settings that are in any way relevant to the provision of health and social care are integrated, including: out-of-hospital (community) services as well as hospitals, GPs' offices, community nurses, and any type of care practitioners, users' homes and volunteer service providers' offices
Other Names:
|
|
Comparator Group
The comparator group receives usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in length of the hospital stay
Time Frame: Days between admission and discharge of patient's admission episodes, measured based on follow up during whole length of study and accumulated at END of study (at month 18)
|
Change in the duration of hospitalization (calculated from admission date and discharge date) measured in days
|
Days between admission and discharge of patient's admission episodes, measured based on follow up during whole length of study and accumulated at END of study (at month 18)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Re-hospitalisation period
Time Frame: Days between last discharge of patient and her/his re-hospitalization, measured based on follow up during whole length of study and accumulated at END of study (at month 18)
|
Re-hospitalisation within 30 days (calculate from admission date and discharge date) measured in days
|
Days between last discharge of patient and her/his re-hospitalization, measured based on follow up during whole length of study and accumulated at END of study (at month 18)
|
|
Patient encounters
Time Frame: Number of registered encounters/contacts between patient and GP, Specialists, Nurse, other involved healthcare providers within the timeframe based on total count in period between start (month 0) end (month 18) of study
|
Encounters and contacts between patient and GP, Specialists, Nurse, other involved healthcare providers
|
Number of registered encounters/contacts between patient and GP, Specialists, Nurse, other involved healthcare providers within the timeframe based on total count in period between start (month 0) end (month 18) of study
|
|
Weight
Time Frame: Weight measured in kilo grams (kg) at baseline (month 0) and at end (month 18) of study duration
|
Weight as disease specific health status measurement
|
Weight measured in kilo grams (kg) at baseline (month 0) and at end (month 18) of study duration
|
|
Blood pressure
Time Frame: Blood pressure measured in mmHg at baseline (month 0) and at end (month 18) of study duration
|
Blood pressure as disease specific health status measurement
|
Blood pressure measured in mmHg at baseline (month 0) and at end (month 18) of study duration
|
|
Heart rate
Time Frame: Heart rate measured in beats per minute (bpm) at baseline and at end of study duration
|
Heart rate pressure as disease specific health status measurement
|
Heart rate measured in beats per minute (bpm) at baseline and at end of study duration
|
|
Oxygen saturation
Time Frame: Oxygen saturation measured in SpO2 (or %) based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Oxygen saturation pressure as disease specific health status measurement
|
Oxygen saturation measured in SpO2 (or %) based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Blood glucose
Time Frame: Blood glucose measured in mg/dl based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Blood glucose pressure as disease specific health status measurement
|
Blood glucose measured in mg/dl based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
HbA1c
Time Frame: HbA1c measured in percentage (%) based on measurement at baseline and at end of study duration
|
HbA1c pressure as disease specific health status measurement
|
HbA1c measured in percentage (%) based on measurement at baseline and at end of study duration
|
|
Creatinine
Time Frame: Creatinine measured in mg/dl based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Creatinine pressure as disease specific health status measurement
|
Creatinine measured in mg/dl based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Charlson Comorbidity Index (CCI)
Time Frame: Charlson Comorbidity Index (CCI) measured in (a) ICD-10-CM and (b) CCI scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Charlson Comorbidity Index (CCI) as a generic health related / functional quality of life
|
Charlson Comorbidity Index (CCI) measured in (a) ICD-10-CM and (b) CCI scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Barthel index
Time Frame: Barthel index measured in index scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Barthel index as a generic health related / functional quality of life
|
Barthel index measured in index scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Self-maintaining and instrumental activities of daily living (IADL)
Time Frame: Self-maintaining and instrumental activities of daily living (IADL) measured in (IADL) scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Self-maintaining and instrumental activities of daily living (IADL) as a generic health related / functional quality of life
|
Self-maintaining and instrumental activities of daily living (IADL) measured in (IADL) scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Geriatric Depression Scale (GDS Short Form)
Time Frame: GDS measured in GDSsf-scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Geriatric Depression Scale (GDS Short Form) as a psychological measure
|
GDS measured in GDSsf-scale based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Anxiety and depression based on HADS
Time Frame: Anxiety and depression according to HADS-scale measurements based on measurement at baseline (month 0) and at end (month 18) of study duration
|
Anxiety and depression (according to HADScale) as a psychological measure
|
Anxiety and depression according to HADS-scale measurements based on measurement at baseline (month 0) and at end (month 18) of study duration
|
|
PIRU questionnaire on user experience (selected questions) of Integrated Care (IC)
Time Frame: User experience (PIRU) measurements based on PIRU-scale measurement at baseline and at end of study duration
|
PIRU questionnaire on user experience of IC as a user perspectives measure
|
User experience (PIRU) measurements based on PIRU-scale measurement at baseline and at end of study duration
|
|
End user perception of service utility according to eCCIS (selected questions)
Time Frame: End user perception of service utility based on eCCIS-scale measurement at baseline (month 0) and at end (month 18) of study duration
|
End user perception of service utility (eCCIS) as a user perspectives measure
|
End user perception of service utility based on eCCIS-scale measurement at baseline (month 0) and at end (month 18) of study duration
|
|
Carer perception of service utility according to eCCIS (selected questions)
Time Frame: Carer perception of service utility based on eCCIS-scale measurement at baseline (month 0) and at end (month 18) of study duration
|
Carer perception of service utility (eCCIS) as a user perspectives measure
|
Carer perception of service utility based on eCCIS-scale measurement at baseline (month 0) and at end (month 18) of study duration
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Panos A Stafylas, Him SA
Publications and helpful links
General Publications
- Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.
- Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014 Dec;12(12):1500-24. doi: 10.1016/j.ijsu.2014.07.014. Epub 2014 Jul 18.
- Berger ML, Dreyer N, Anderson F, Towse A, Sedrakyan A, Normand SL. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. Value Health. 2012 Mar-Apr;15(2):217-30. doi: 10.1016/j.jval.2011.12.010.
- Piera-Jimenez J, Daugbjerg S, Stafylas P, Meyer I, Muller S, Lewis L, da Col P, Folkvord F, Lupianez-Villanueva F. BeyondSilos, a Telehealth-Enhanced Integrated Care Model in the Domiciliary Setting for Older Patients: Observational Prospective Cohort Study for Effectiveness and Cost-Effectiveness Assessments. JMIR Med Inform. 2020 Oct 6;8(10):e20938. doi: 10.2196/20938.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BeyondSilos_CIP_No.621069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on New Care
-
Him SACompletedFrail Elderly Syndrome | Congestive Heart Failure | Falls Prevention
-
Him SAUnknownDiabetes | Chronic Obstructive Pulmonary Disease | Frail Elderly Syndrome | Chronic Heart FailureCroatia, Italy, Poland, Spain, United Kingdom
-
Unity Health TorontoRecruitingGestational Diabetes Mellitus in PregnancyCanada
-
Alberta Bone and Joint Health InstituteAlberta Health & Wellness; Calgary Health Region; Alberta Medical Association; David... and other collaboratorsCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipCanada
-
Charite University, Berlin, GermanyLudwig-Maximilians - University of Munich, The Institute for Medical Information... and other collaboratorsCompletedFrailty | Frail ElderlyGermany
-
University of PittsburghCompletedPatient Centered CareUnited States
-
Charite University, Berlin, GermanyCompleted
-
University Hospital, GenevaFondation Privée des HUG; IF International FoundationRecruitingRecovery | Psychiatric Hospitalization | CoercionSwitzerland
-
Ege UniversityCompletedIncontinence-associated Dermatitis | Nursing CareTurkey
-
Université de SherbrookeActive, not recruitingCardiovascular Diseases | Smoking | Hypertension | Obesity | Diabetes Mellitus, Type 2 | DyslipidemiasCanada